New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

Russell S. Roberson; Andrew D. Shaw

doi:10.3909/ricm0642

New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

Russell S. Roberson, Andrew D. Shaw

Anesthesiology & Pain Management

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e46-e48
Journal	Reviews in Cardiovascular Medicine
Volume	13
Issue number	1
DOIs	https://doi.org/10.3909/ricm0642
State	Published - 2012

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.3909/ricm0642

Cite this

@article{89cdd4be06ee4b41a2b21dff7eb18657,

title = "New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban",

author = "Roberson, {Russell S.} and Shaw, {Andrew D.}",

year = "2012",

doi = "10.3909/ricm0642",

language = "English (US)",

volume = "13",

pages = "e46--e48",

journal = "Reviews in Cardiovascular Medicine",

issn = "1530-6550",

publisher = "MedReviews LLC",

number = "1",

}

TY - JOUR

T1 - New oral anticoagulants for atrial fibrillation

T2 - The factor Xa inhibitors rivaroxaban and apixaban

AU - Roberson, Russell S.

AU - Shaw, Andrew D.

PY - 2012

Y1 - 2012

UR - http://www.scopus.com/inward/record.url?scp=84863093673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863093673&partnerID=8YFLogxK

U2 - 10.3909/ricm0642

DO - 10.3909/ricm0642

M3 - Comment/debate

C2 - 22565540

AN - SCOPUS:84863093673

SN - 1530-6550

VL - 13

SP - e46-e48

JO - Reviews in Cardiovascular Medicine

JF - Reviews in Cardiovascular Medicine

IS - 1

ER -

New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this